CR Intrinsic Investors’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
2013
Q3
$4.83M Buy